| 產品名稱 | BAY 19-8004 - Lirimilast |
| 產品貨號 | Axon 1178 CAS [329306-27-6] MF C17H12Cl2N2O6SMW 443.26 Purity: 98% Soluble in DMSO Description Selective inhibitor of phosphodiesterase-4 (PDE4) References Certificates Categories Extra info D.C. Grootendorst et al. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). Pulmonary Pharmacol. Ther. 16 (2003) 341–347. ? P. Norman.?PDE4 inhibitors: sustained patenting activity as leading drugs near the market. Exp. Opin. Ther. Pat.2000, 10, 9, 1415-1427. ? D.C. Grootendorst, K.F. Rabe.?Selective phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. Curr. Opin. Allergy Clin. Immunol. 2002, 2(1), 61-67. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology CNS Pain & Inflammation EC 3.1.4.53 PDE PDE4 inhibitor Chemical name Methanesulfonic acid 2-(2,4-dichloro-benzoyl)-3-ureido-benzofuran-6-yl ester Parent CAS No. [329306-27-6] Order Size Unit Price Stock 5 mg €135.00 In Stock |
| 產品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產品規(guī)格 | |
| 產品品牌 | axonmedchem |
| 產品概述 | |
| 產品詳情 |
BAY 19-8004 - LirimilastAxon 1178 CAS [329306-27-6] MF C17H12Cl2N2O6S
Description
Selective inhibitor of phosphodiesterase-4 (PDE4)
PDE4 inhibitor
Chemical nameMethanesulfonic acid 2-(2,4-dichloro-benzoyl)-3-ureido-benzofuran-6-yl ester Parent CAS No.[329306-27-6] |
| 產品資料 |
